Does EMPAGLIFLOZIN Cause Osteoarthritis? 61 Reports in FDA Database

Q: Does EMPAGLIFLOZIN cause Osteoarthritis?

61 reports of Osteoarthritis have been filed with the FDA for EMPAGLIFLOZIN, representing 0.2% of all EMPAGLIFLOZIN adverse event reports.

Q: How dangerous is Osteoarthritis from EMPAGLIFLOZIN?

Of 61 reports, 1 (1.6%) resulted in death and 42 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 61 reports of Osteoarthritis have been filed in association with EMPAGLIFLOZIN (Jardiance). This represents 0.2% of all adverse event reports for EMPAGLIFLOZIN.

Reports of Osteoarthritis with EMPAGLIFLOZIN

0.2%

of all EMPAGLIFLOZIN reports

Deaths

Hospitalizations

How Dangerous Is Osteoarthritis From EMPAGLIFLOZIN?

Of the 61 reports, 1 (1.6%) resulted in death, 42 (68.9%) required hospitalization, and 7 (11.5%) were considered life-threatening.

Is Osteoarthritis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EMPAGLIFLOZIN. However, 61 reports have been filed with the FAERS database.

What Other Side Effects Does EMPAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,644) Fungal infection (1,941) Blood glucose increased (1,797) Euglycaemic diabetic ketoacidosis (1,769) Weight decreased (1,661) Urinary tract infection (1,439)